🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
BEYOND represents an open-label, parallel, three-arm randomized controlled ...
Status
Completed
Location
Unit of Endocrinology and Metabolic Diseases
Start Date
2019-11-27
Trial ID
NCT04196231
Treatments Being Tested
The purpose of this clinical research study is to learn if BMS-512148 (Dapa...
Status
Completed
Location
Local Institution
Start Date
2010-06
Trial ID
NCT01095666
Treatments Being Tested
The primary objective of this study is to evaluate the bioequivalence betwe...
Status
Completed
Location
Pharma Medica Research Inc.
Start Date
2020-12-14
Trial ID
NCT04880993
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of Lima as...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-12
Trial ID
NCT03766750
Treatments Being Tested
This is a long term, single arm, open label study to evaluate the safety an...
Status
Completed
Location
Research Site
Start Date
2011-02
Trial ID
NCT01294436
Treatments Being Tested
The purpose of this study is to evaluate the effects of dapagliflozin to pr...
Status
Terminated
Location
University Of Texas Health Center At San Antonio
Start Date
2009-06
Trial ID
NCT00726505
Treatments Being Tested
To evaluate the safety and pharmacokinetic characteristics of AJU-A51 in he...
Status
Completed
Location
Jang Hee Hong
Start Date
2020-08-01
Trial ID
NCT04972539
Treatments Being Tested
Study will evaluate if a combination of saxagliptin and dapagliflozin added...
Status
Completed
Location
Research Site
Start Date
2014-09-09
Trial ID
NCT02284893
This study will enroll eligible subjects into a long-term safety study (Par...
Status
Completed
Location
Research Site
Start Date
2015-10-26
Trial ID
NCT02582814
Treatments Being Tested
Dapagliflozin reduces the risk of de novo heart failure (HF) in diabetics a...
Status
Completed
Location
Hospital Clinico Universitario Virgen de la Arrixaca
Start Date
2021-02-08
Trial ID
NCT04707352
Treatments Being Tested